FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312156827> ?p ?o ?g. }

• W4312156827 endingPage "822" @default.
• W4312156827 startingPage "810" @default.
• W4312156827 abstract "Heavily treatment-experienced (HTE) people with human immunodeficiency virus (HIV) (PWH) may not achieve virologic suppression (VS) with combination antiretroviral therapy due to multidrug resistance (MDR), intolerance, and safety concerns. These PWH often receive highly individualized treatment regimens, but these regimens may not enable PWH to achieve VS, thereby halting disease progression. Novel medications are required for treating individuals with MDR HIV. Lenacapavir (LEN), a first-in-class HIV capsid inhibitor, is under investigation for the treatment of HTE individuals with MDR HIV in the phase 2/3 CAPELLA study. This study aimed to compare LEN plus optimized background regimen (OBR) with fostemsavir (FTR) + OBR, ibalizumab (IBA) + OBR, and OBR alone in terms of VS, CD4 cell count change from baseline, immunologic recovery, and discontinuation due to adverse events, using indirect treatment comparisons.A systematic review identified clinical evidence on HIV-1 treatments in HTE PWH. A feasibility assessment evaluated the identified studies for indirect treatment comparison analyses based on population characteristics, interventions, comparators, and outcomes of interest. Unanchored simulated treatment comparisons of LEN + OBR versus comparators were conducted.LEN + OBR had 6.57 times higher odds of VS at weeks 24 to 28 than FTR + OBR (95% confidence interval [CI] 1.34-32.28), 8.93 times higher odds of VS than IBA + OBR (95% CI 2.07-38.46), and 12.74 times higher odds of VS than OBR alone (95% CI 1.70-95.37). Change from baseline in CD4 cell count was similar across LEN + OBR, FTR + OBR, and IBA + OBR.LEN + OBR has statistically significantly greater odds of VS at weeks 24 to 28 than its comparators and represents a novel treatment for people with MDR HIV." @default.
• W4312156827 created "2023-01-04" @default.
• W4312156827 creator A5007839538 @default.
• W4312156827 creator A5050963757 @default.
• W4312156827 creator A5061169068 @default.
• W4312156827 creator A5071630767 @default.
• W4312156827 creator A5079907731 @default.
• W4312156827 creator A5085171999 @default.
• W4312156827 creator A5087152382 @default.
• W4312156827 date "2023-06-01" @default.
• W4312156827 modified "2023-09-26" @default.
• W4312156827 title "Indirect Treatment Comparisons of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multidrug-Resistant Human Immunodeficiency Virus" @default.
• W4312156827 cites W15667978 @default.
• W4312156827 cites W1967284000 @default.
• W4312156827 cites W1976489822 @default.
• W4312156827 cites W1978739962 @default.
• W4312156827 cites W1982681524 @default.
• W4312156827 cites W1995364703 @default.
• W4312156827 cites W2001765285 @default.
• W4312156827 cites W2012666111 @default.
• W4312156827 cites W2016173606 @default.
• W4312156827 cites W2022731930 @default.
• W4312156827 cites W2037668591 @default.
• W4312156827 cites W2059758520 @default.
• W4312156827 cites W2082723185 @default.
• W4312156827 cites W2094811879 @default.
• W4312156827 cites W2095361185 @default.
• W4312156827 cites W2095745799 @default.
• W4312156827 cites W2098923148 @default.
• W4312156827 cites W2121179908 @default.
• W4312156827 cites W2133117185 @default.
• W4312156827 cites W2150504993 @default.
• W4312156827 cites W2152505869 @default.
• W4312156827 cites W2461009619 @default.
• W4312156827 cites W2531269403 @default.
• W4312156827 cites W2561768952 @default.
• W4312156827 cites W2742200330 @default.
• W4312156827 cites W2767724157 @default.
• W4312156827 cites W2771626406 @default.
• W4312156827 cites W2809506549 @default.
• W4312156827 cites W2886705643 @default.
• W4312156827 cites W2947571847 @default.
• W4312156827 cites W2969584959 @default.
• W4312156827 cites W2973091596 @default.
• W4312156827 cites W3013800457 @default.
• W4312156827 cites W3026455320 @default.
• W4312156827 cites W3040374393 @default.
• W4312156827 cites W3086843780 @default.
• W4312156827 cites W3091955100 @default.
• W4312156827 cites W3092824650 @default.
• W4312156827 cites W3120035848 @default.
• W4312156827 cites W3129864761 @default.
• W4312156827 cites W4211183388 @default.
• W4312156827 cites W4213428638 @default.
• W4312156827 cites W4241267536 @default.
• W4312156827 cites W4280564133 @default.
• W4312156827 doi "https://doi.org/10.1016/j.jval.2022.12.011" @default.
• W4312156827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36566886" @default.
• W4312156827 hasPublicationYear "2023" @default.
• W4312156827 type Work @default.
• W4312156827 citedByCount "3" @default.
• W4312156827 countsByYear W43121568272023 @default.
• W4312156827 crossrefType "journal-article" @default.
• W4312156827 hasAuthorship W4312156827A5007839538 @default.
• W4312156827 hasAuthorship W4312156827A5050963757 @default.
• W4312156827 hasAuthorship W4312156827A5061169068 @default.
• W4312156827 hasAuthorship W4312156827A5071630767 @default.
• W4312156827 hasAuthorship W4312156827A5079907731 @default.
• W4312156827 hasAuthorship W4312156827A5085171999 @default.
• W4312156827 hasAuthorship W4312156827A5087152382 @default.
• W4312156827 hasBestOaLocation W43121568271 @default.
• W4312156827 hasConcept C126322002 @default.
• W4312156827 hasConcept C142462285 @default.
• W4312156827 hasConcept C156957248 @default.
• W4312156827 hasConcept C197934379 @default.
• W4312156827 hasConcept C203014093 @default.
• W4312156827 hasConcept C2778715236 @default.
• W4312156827 hasConcept C2781413609 @default.
• W4312156827 hasConcept C2908647359 @default.
• W4312156827 hasConcept C3013748606 @default.
• W4312156827 hasConcept C44249647 @default.
• W4312156827 hasConcept C71924100 @default.
• W4312156827 hasConcept C99454951 @default.
• W4312156827 hasConceptScore W4312156827C126322002 @default.
• W4312156827 hasConceptScore W4312156827C142462285 @default.
• W4312156827 hasConceptScore W4312156827C156957248 @default.
• W4312156827 hasConceptScore W4312156827C197934379 @default.
• W4312156827 hasConceptScore W4312156827C203014093 @default.
• W4312156827 hasConceptScore W4312156827C2778715236 @default.
• W4312156827 hasConceptScore W4312156827C2781413609 @default.
• W4312156827 hasConceptScore W4312156827C2908647359 @default.
• W4312156827 hasConceptScore W4312156827C3013748606 @default.
• W4312156827 hasConceptScore W4312156827C44249647 @default.
• W4312156827 hasConceptScore W4312156827C71924100 @default.
• W4312156827 hasConceptScore W4312156827C99454951 @default.
• W4312156827 hasFunder F4320308573 @default.
• W4312156827 hasIssue "6" @default.
• W4312156827 hasLocation W43121568271 @default.

• next